<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Muana Minkoué, Author at BioAlps</title>
	<atom:link href="https://bioalps.org/author/muana/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioalps.org/author/muana/</link>
	<description>Your entry point to a wealth of contacts, know-how and knowledge, for both personal and institutional support: BioAlps, the life science cluster of Western Switzerland.</description>
	<lastBuildDate>Mon, 11 May 2026 12:41:35 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioalps.org/app/uploads/2022/11/cropped-favicon-32x32.png</url>
	<title>Muana Minkoué, Author at BioAlps</title>
	<link>https://bioalps.org/author/muana/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Subscribe to our newsletter</title>
		<link>https://bioalps.org/test-stes/</link>
		
		<dc:creator><![CDATA[Muana Minkoué]]></dc:creator>
		<pubDate>Mon, 11 May 2026 12:35:18 +0000</pubDate>
				<category><![CDATA[Non classé]]></category>
		<guid isPermaLink="false">https://bioalps.org/?p=36851</guid>

					<description><![CDATA[<p><img width="310" height="95" src="https://bioalps.org/app/uploads/2024/02/2024_cercle_bioalps.png" class="attachment-large size-large wp-post-image default-featured-img" alt="" style="float:left; margin:0 15px 15px 0;" decoding="async" srcset="https://bioalps.org/app/uploads/2024/02/2024_cercle_bioalps.png 310w, https://bioalps.org/app/uploads/2024/02/2024_cercle_bioalps-300x92.png 300w" sizes="(max-width: 310px) 100vw, 310px" /></p>
<p>The post <a href="https://bioalps.org/test-stes/">Subscribe to our newsletter</a> appeared first on <a href="https://bioalps.org">BioAlps</a>.</p>
]]></description>
										<content:encoded><![CDATA[<img width="310" height="95" src="https://bioalps.org/app/uploads/2024/02/2024_cercle_bioalps.png" class="attachment-large size-large wp-post-image default-featured-img" alt="" style="float:left; margin:0 15px 15px 0;" decoding="async" loading="lazy" srcset="https://bioalps.org/app/uploads/2024/02/2024_cercle_bioalps.png 310w, https://bioalps.org/app/uploads/2024/02/2024_cercle_bioalps-300x92.png 300w" sizes="auto, (max-width: 310px) 100vw, 310px" /><p>The post <a href="https://bioalps.org/test-stes/">Subscribe to our newsletter</a> appeared first on <a href="https://bioalps.org">BioAlps</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>European Academy of Neurology &#8211; Start-up Corner</title>
		<link>https://bioalps.org/european-academy-of-neurology-start-up-corner/</link>
		
		<dc:creator><![CDATA[Muana Minkoué]]></dc:creator>
		<pubDate>Fri, 27 Feb 2026 09:30:28 +0000</pubDate>
				<category><![CDATA[Opportunities]]></category>
		<guid isPermaLink="false">https://bioalps.org/?p=36320</guid>

					<description><![CDATA[<p><img width="768" height="477" src="https://bioalps.org/app/uploads/2025/06/EAN-Congress.png" class="attachment-large size-large wp-post-image" alt="EAN Congress" style="float:left; margin:0 15px 15px 0;" decoding="async" loading="lazy" srcset="https://bioalps.org/app/uploads/2025/06/EAN-Congress.png 768w, https://bioalps.org/app/uploads/2025/06/EAN-Congress-300x186.png 300w" sizes="auto, (max-width: 768px) 100vw, 768px" />Startups in neurological field can showcase their advancements at the 12th Congress of the European Academy of Neurology (EAN) in Palexpo Geneva from 27 &#8211; 30 June. The EAN Congress is one of the leading neurology events worldwide, a hybrid annual meeting uniting clinicians, researchers, educators, industry partners, residents, students, and patient representatives for four&#8230;</p>
<p>The post <a href="https://bioalps.org/european-academy-of-neurology-start-up-corner/">European Academy of Neurology &#8211; Start-up Corner</a> appeared first on <a href="https://bioalps.org">BioAlps</a>.</p>
]]></description>
										<content:encoded><![CDATA[<img width="768" height="477" src="https://bioalps.org/app/uploads/2025/06/EAN-Congress.png" class="attachment-large size-large wp-post-image" alt="EAN Congress" style="float:left; margin:0 15px 15px 0;" decoding="async" loading="lazy" srcset="https://bioalps.org/app/uploads/2025/06/EAN-Congress.png 768w, https://bioalps.org/app/uploads/2025/06/EAN-Congress-300x186.png 300w" sizes="auto, (max-width: 768px) 100vw, 768px" />
<h3 class="wp-block-heading">Startups in neurological field can showcase their advancements at the 12th Congress of the European Academy of Neurology (EAN) in Palexpo Geneva from 27 &#8211; 30 June.</h3>



<p><br><br><a href="https://www.ean.org/congress2026" target="_blank" rel="noreferrer noopener">The EAN Congress</a> is one of the leading neurology events worldwide, a hybrid annual meeting uniting clinicians, researchers, educators, industry partners, residents, students, and patient representatives for four days of science and education.</p>



<p></p>



<h4 class="wp-block-heading"><br><br><br><strong>To qualify as start-up, the following criteria must be fulfilled.</strong></h4>



<p>The submitting company:</p>



<ul class="wp-block-list">
<li>has not been founded more than ten years ago.</li>



<li>features (highly) innovative technologies and/or business models.</li>



<li>has or strives for significant employee and/or sales growth.</li>



<li>must not receive substantial financial resources from an existing company in the field of neurology.</li>



<li>must not have had a booth at an EAN Congress prior to applying for the first time. </li>
</ul>



<p></p>



<h4 class="wp-block-heading"><br><br><strong>Start-up Package</strong> &#8211; <strong>€ 2,500</strong></h4>



<ul class="wp-block-list">
<li>Booth (approximately 4m²) with backwall and furniture (counter, barstool, brochure stand, carpet, power socket).</li>



<li>Basic cleaning and waste disposal</li>



<li>Exhibitor badges with access to the exhibition and 1 transferable badge with access to the EAN congress programme</li>



<li>Access to the exhibitor lounge with catering.</li>



<li>One company profile on the virtual congress platform and app.</li>



<li>Acknowledgement as a start-up on the acknowledgment board onsite, the congress website, virtual platfom and app.</li>
</ul>



<p></p>



<h4 class="wp-block-heading"><br><br><strong>Start-up Booth + Start-up Talk Package &#8211; € 6,500</strong></h4>



<p>Includes all benefits of the Start-up Booth Package, plus:.</p>



<ul class="wp-block-list">
<li>10-minute Start-up Talk during a dedicated 30min pitch sesion in the Neuro Theatre with stard AV equipment (held during the afternoon coffe break on Saturday, Sunday, or Monday).</li>



<li>Announcement of the programme in the industry pocket programme, the Congress App and on-site at the Neuro Theatre.</li>
</ul>



<p></p>



<h4 class="wp-block-heading"><br><br><strong>How to apply</strong></h4>



<p>Interested to find out more? The process is simple: write us an e-mail to <strong>&#x69;n&#x64;&#117;&#x73;&#116;r&#x79;&#64;&#x65;&#97;n&#x2e;&#111;&#x72;&#103;</strong> and tell us about your start-up and why you would like to be part of the EAN Start-up Corner.</p>
<p>The post <a href="https://bioalps.org/european-academy-of-neurology-start-up-corner/">European Academy of Neurology &#8211; Start-up Corner</a> appeared first on <a href="https://bioalps.org">BioAlps</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>FutureHealth Lausanne announced its Innovation Challenge 2025 winners</title>
		<link>https://bioalps.org/futurehealth-lausanne-announced-its-innovation-challenge-2025-winners/</link>
		
		<dc:creator><![CDATA[Muana Minkoué]]></dc:creator>
		<pubDate>Thu, 21 Aug 2025 09:10:19 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Innovation]]></category>
		<category><![CDATA[Life Sciences]]></category>
		<guid isPermaLink="false">https://bioalps.org/?p=34329</guid>

					<description><![CDATA[<p><img width="768" height="477" src="https://bioalps.org/app/uploads/2025/08/Innovation-Challenge-winners.png" class="attachment-large size-large wp-post-image" alt="" style="float:left; margin:0 15px 15px 0;" decoding="async" loading="lazy" srcset="https://bioalps.org/app/uploads/2025/08/Innovation-Challenge-winners.png 768w, https://bioalps.org/app/uploads/2025/08/Innovation-Challenge-winners-300x186.png 300w" sizes="auto, (max-width: 768px) 100vw, 768px" />The 15 winners of the FutureHealth Lausanne 2025 Innovation Challenge – selected by the FutureHealth Ecosystem – have been unveiled. &#160; &#160; For the first time, FutureHealth Lausanne carried out an Innovation Challenge &#8211; powered by the Canton of Vaud, Biopôle, BioAlps and the city of Lausanne. Health Innovators had the opportunity to showcase their&#8230;</p>
<p>The post <a href="https://bioalps.org/futurehealth-lausanne-announced-its-innovation-challenge-2025-winners/">FutureHealth Lausanne announced its Innovation Challenge 2025 winners</a> appeared first on <a href="https://bioalps.org">BioAlps</a>.</p>
]]></description>
										<content:encoded><![CDATA[<img width="768" height="477" src="https://bioalps.org/app/uploads/2025/08/Innovation-Challenge-winners.png" class="attachment-large size-large wp-post-image" alt="" style="float:left; margin:0 15px 15px 0;" decoding="async" loading="lazy" srcset="https://bioalps.org/app/uploads/2025/08/Innovation-Challenge-winners.png 768w, https://bioalps.org/app/uploads/2025/08/Innovation-Challenge-winners-300x186.png 300w" sizes="auto, (max-width: 768px) 100vw, 768px" /><h2>The 15 winners of the FutureHealth Lausanne 2025 Innovation Challenge – selected by the FutureHealth Ecosystem – have been unveiled.</h2>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>For the first time, <a href="https://www.futurehealth.swiss/en/future-health-lausanne-start/konferenz" target="_blank" rel="noopener">FutureHealth Lausanne </a> carried out an Innovation Challenge &#8211; powered by the <a href="https://www.vaud-economie.ch/" target="_blank" rel="noopener">Canton of Vaud</a>, <a href="https://www.biopole.ch/" target="_blank" rel="noopener">Biopôle</a>, BioAlps and the city of Lausanne.</p>
<p>Health Innovators had the opportunity to showcase their innovative solutions to high-level decision-makers and key opinion leaders.</p>
<p>On 30 September, the top five winners will pitch their breakthrough solutions live on stage, showcasing ideas set to transform healthcare.<br />
Three companies from the Swiss Health Valley have been selected:</p>
<ul>
<li style="list-style-type: none">
<ul>
<li><a href="https://www.artiria-medical.com/" target="_blank" rel="noopener">Artiria Medical</a></li>
<li><a href="https://lagosta.com/" target="_blank" rel="noopener">Lagosta</a></li>
<li><a href="https://www.virtuosis.ai/" target="_blank" rel="noopener">Virtuosis AI</a></li>
</ul>
</li>
</ul>
<p>&nbsp;</p>
<p>Participants of the FutureHealth Lausanne 2025 will get to explore all 15 selected winning solutions in the innovation zone.</p>
<p><a href="https://bioalps.org/futurehealth-lausanne/">Join us on 30 September</a>, to connect with leaders, decision-makers, and visionaries who are actively shaping the future of healthcare.</p>
<p>You&#8217;ll witness groundbreaking solutions, discover emerging innovations, and engage directly with the people turning ambition into action!</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p><strong>Source: FutureHealth Lausanne</strong></p>
<p>The post <a href="https://bioalps.org/futurehealth-lausanne-announced-its-innovation-challenge-2025-winners/">FutureHealth Lausanne announced its Innovation Challenge 2025 winners</a> appeared first on <a href="https://bioalps.org">BioAlps</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Oculis Upsized Loan Facility to Access up to CHF 100 million</title>
		<link>https://bioalps.org/oculis-upsized-loan-facility-to-access-up-to-chf-100-million/</link>
		
		<dc:creator><![CDATA[Muana Minkoué]]></dc:creator>
		<pubDate>Thu, 21 Aug 2025 07:55:17 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Funds]]></category>
		<category><![CDATA[Life Sciences]]></category>
		<guid isPermaLink="false">https://bioalps.org/?p=34326</guid>

					<description><![CDATA[<p><img width="768" height="477" src="https://bioalps.org/app/uploads/2022/10/BioAlps-Website-768x477-19.png" class="attachment-large size-large wp-post-image" alt="Oculis" style="float:left; margin:0 15px 15px 0;" decoding="async" loading="lazy" srcset="https://bioalps.org/app/uploads/2022/10/BioAlps-Website-768x477-19.png 768w, https://bioalps.org/app/uploads/2022/10/BioAlps-Website-768x477-19-300x186.png 300w" sizes="auto, (max-width: 768px) 100vw, 768px" />Oculis Holding AG, a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs, announced that it has amended its loan facility (the “Amended Loan Agreement”) with funds and accounts managed by BlackRock (the “Lender”). &#160; &#160; The Amended Loan Agreement replaces the prior loan agreement between Oculis and&#8230;</p>
<p>The post <a href="https://bioalps.org/oculis-upsized-loan-facility-to-access-up-to-chf-100-million/">Oculis Upsized Loan Facility to Access up to CHF 100 million</a> appeared first on <a href="https://bioalps.org">BioAlps</a>.</p>
]]></description>
										<content:encoded><![CDATA[<img width="768" height="477" src="https://bioalps.org/app/uploads/2022/10/BioAlps-Website-768x477-19.png" class="attachment-large size-large wp-post-image" alt="Oculis" style="float:left; margin:0 15px 15px 0;" decoding="async" loading="lazy" srcset="https://bioalps.org/app/uploads/2022/10/BioAlps-Website-768x477-19.png 768w, https://bioalps.org/app/uploads/2022/10/BioAlps-Website-768x477-19-300x186.png 300w" sizes="auto, (max-width: 768px) 100vw, 768px" /><h2>Oculis Holding AG, a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs, announced that it has amended its loan facility (the “Amended Loan Agreement”) with funds and accounts managed by BlackRock (the “Lender”).</h2>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>The Amended Loan Agreement replaces the prior loan agreement between Oculis and the Lender dated May 29, 2024, and the upsized structure will provide CHF 75.0 million in borrowing capacity (which may be increased to up to CHF 100.0 million) (the “Loan”).</p>
<p>The Loan comprises tranches 1, 2 and 3, in the amounts of CHF 25.0 million each, as well as an additional loan of up to CHF 25.0 million, which may be made available by the Lender to Oculis on mutually agreed terms. No amounts were drawn at signing.</p>
<p>Access to this additional capital offers significant financial flexibility beyond Oculis’ current cash reserves as the Company moves toward upcoming key milestones across all three core assets: regulatory discussions with the FDA on three indications investigated with Privosegtor (OCS-05) for acute optic neuritis, non-arteritic anterior ischemic optic neuritis (NAION), and treatment of acute relapses in multiple sclerosis (MS) during 2H 2025; initiation of Licaminlimab (OCS-02) Phase 2/3 trial for dry eye disease in 2H 2025; initiation of Privosegtor (OCS-05) Phase 2/3 trial for acute optic neuritis in 1H 2026; OCS-01 Phase 3 DIAMOND trials’ topline results in Q2 2026, and if positive, its first NDA filing in 2H 2026.</p>
<p>Riad Sherif, M.D., Chief Executive Officer of Oculis, said, “We are pleased to have upsized our previous loan agreement with funds and accounts managed by BlackRock, which expands an instrument allowing enhanced flexibility to ensure the future financial and operational strength of Oculis. Our current robust cash position provides runway into early 2028, which is further strengthened by the loan facility, as we remain focused on advancing our portfolio of differentiated assets and bringing transformative treatments to those who need them most.”</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p><a href="https://investors.oculis.com/news-releases/news-release-details/oculis-upsized-loan-facility-access-chf-100-million" target="_blank" rel="noopener"><strong>Source: press release </strong></a></p>
<p>The post <a href="https://bioalps.org/oculis-upsized-loan-facility-to-access-up-to-chf-100-million/">Oculis Upsized Loan Facility to Access up to CHF 100 million</a> appeared first on <a href="https://bioalps.org">BioAlps</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Campus Biotech: At the heart of networked innovation</title>
		<link>https://bioalps.org/campus-biotech-at-the-heart-of-networked-innovation/</link>
		
		<dc:creator><![CDATA[Muana Minkoué]]></dc:creator>
		<pubDate>Thu, 14 Aug 2025 13:53:41 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<guid isPermaLink="false">https://bioalps.org/?p=34272</guid>

					<description><![CDATA[<p><img width="768" height="477" src="https://bioalps.org/app/uploads/2025/08/Campus-biotech-podcast.png" class="attachment-large size-large wp-post-image" alt="" style="float:left; margin:0 15px 15px 0;" decoding="async" loading="lazy" srcset="https://bioalps.org/app/uploads/2025/08/Campus-biotech-podcast.png 768w, https://bioalps.org/app/uploads/2025/08/Campus-biotech-podcast-300x186.png 300w" sizes="auto, (max-width: 768px) 100vw, 768px" />A shared perspective on two podcast episodes at the heart of Geneva’s scientific life. &#160; &#160; How can academic research, technological innovation, entrepreneurship, and patient impact come together and speak the same language?Through the first two episodes of the Where Science Talks podcast, Campus Biotech gives voice to the people shaping a vibrant and interconnected&#8230;</p>
<p>The post <a href="https://bioalps.org/campus-biotech-at-the-heart-of-networked-innovation/">Campus Biotech: At the heart of networked innovation</a> appeared first on <a href="https://bioalps.org">BioAlps</a>.</p>
]]></description>
										<content:encoded><![CDATA[<img width="768" height="477" src="https://bioalps.org/app/uploads/2025/08/Campus-biotech-podcast.png" class="attachment-large size-large wp-post-image" alt="" style="float:left; margin:0 15px 15px 0;" decoding="async" loading="lazy" srcset="https://bioalps.org/app/uploads/2025/08/Campus-biotech-podcast.png 768w, https://bioalps.org/app/uploads/2025/08/Campus-biotech-podcast-300x186.png 300w" sizes="auto, (max-width: 768px) 100vw, 768px" /><h2>A shared perspective on two podcast episodes at the heart of Geneva’s scientific life.</h2>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>How can academic research, technological innovation, entrepreneurship, and patient impact come together and speak the same language?Through the first two episodes of the <a href="https://campusbiotech.ch/podcast/" target="_blank" rel="noopener">Where Science Talks podcast</a>, <a href="https://campusbiotech.ch/" target="_blank" rel="noopener">Campus Biotech</a> gives voice to the people shaping a vibrant and interconnected ecosystem.</p>
<p>&nbsp;</p>
<h4>Campus Biotech: a catalyst for innovation in life sciences</h4>
<p>In the first episode, Erwin Bottinger (CEO of the <a href="https://wysscenter.ch/">Wyss Center</a>, a nonprofit neurotechnology venture builder translating R&amp;D into clinical and market impact), Antonio Gambardella (Director of <a href="https://www.fongit.ch/" target="_blank" rel="noopener">FONGIT</a>, Geneva’s incubator for tech start-ups), and Nicolas Vachicouras (CEO and co-founder of <a href="https://www.neurosoft-bio.com/" target="_blank" rel="noopener">Neurosoft Bioelectronics</a>, a start-up developing next-generation brain interfaces) share a common belief: Campus Biotech provides a unique environment where research, entrepreneurship and industrialization reinforce one another.</p>
<p><a href="https://campusbiotech.ch/podcast/01-where-science-meets-innovation/" target="_blank" rel="noopener">Listen to the podcast</a></p>
<p>&nbsp;</p>
<h4>Swiss Health Valley: a regional dynamic driven by BioAlps</h4>
<p>In the second episode, Magali Bischof, Secretary General of <a href="http://bioalps.org">BioAlps</a>, and Sebastien Mazzuri, Director of R&amp;I at the <a href="https://esperare.org/" target="_blank" rel="noopener">Esperare Foundation</a>, provide a complementary perspective at the regional level.</p>
<p>The Swiss Health Valley encompasses all life sciences stakeholders in Western Switzerland: research institutes, hospitals, innovative SMEs, major corporations, cantons and innovation hubs.</p>
<p>BioAlps acts as a catalyst for interaction — identifying experts, fostering connections, and raising the visibility of talent and projects.<br />
“The diversity of the ecosystem is its greatest strength,” notes Magali Bischof, who highlights the importance of inter-cantonal collaboration and the key role of events in sparking meaningful encounters.</p>
<p>Based at Campus Biotech, the Esperare Foundation illustrates an original model that combines philanthropic funding with a therapeutic development mindset.</p>
<p><a href="https://campusbiotech.ch/podcast/02-the-power-of-collaboration-in-the-swiss-health-valley/" target="_blank" rel="noopener">Listen to the podcast </a></p>
<p>&nbsp;</p>
<h4>A Territory of Impact, from Local to Global</h4>
<p>What emerges from both episodes is the power of intelligent network—from the site itself to the broader region. Campus Biotech acts as a point of convergence: a place for creation, exchange with key institutions and partners, and co-development.</p>
<p>Closely connected to it, the Swiss Health Valley provides the regional foundation in which these dynamics take root. BioAlps plays a key role in orchestrating this ecosystem: the team connects stakeholders, promotes projects, and supports initiatives on the ground.</p>
<p>Rooted in Geneva and Western Switzerland, yet international by nature, this ecosystem draws on the density of talent, the complementarity of approaches, and the fluidity of individual trajectories. All with a shared goal: to turn science into tangible, accessible, and patient-relevant solutions.</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p><strong>Source: Campus Biotech</strong></p>
<p>The post <a href="https://bioalps.org/campus-biotech-at-the-heart-of-networked-innovation/">Campus Biotech: At the heart of networked innovation</a> appeared first on <a href="https://bioalps.org">BioAlps</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Three Geneva-based startups receive funding from the FONGIT Innovation Fund (FIF)</title>
		<link>https://bioalps.org/three-geneva-based-startups-receive-funding-from-the-fongit-innovation-fund-fif/</link>
		
		<dc:creator><![CDATA[Muana Minkoué]]></dc:creator>
		<pubDate>Thu, 24 Apr 2025 08:23:06 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Diagnostic]]></category>
		<category><![CDATA[Funding]]></category>
		<category><![CDATA[Innovation]]></category>
		<category><![CDATA[Life Sciences]]></category>
		<category><![CDATA[startups]]></category>
		<guid isPermaLink="false">https://bioalps.org/?p=33238</guid>

					<description><![CDATA[<p><img width="768" height="477" src="https://bioalps.org/app/uploads/2025/04/EarlySight-768x477-1.png" class="attachment-large size-large wp-post-image" alt="" style="float:left; margin:0 15px 15px 0;" decoding="async" loading="lazy" srcset="https://bioalps.org/app/uploads/2025/04/EarlySight-768x477-1.png 768w, https://bioalps.org/app/uploads/2025/04/EarlySight-768x477-1-300x186.png 300w" sizes="auto, (max-width: 768px) 100vw, 768px" />Three life sciences projects from Geneva have been awarded funding through the FONGIT Innovation Fund (FIF), underscoring the canton’s strong commitment to driving innovation and advancing sustainable solutions. &#160; &#160; CHF 100,000 FIF Seed Loan awarded to BrainScape Medical: Creating Solutions for Optimised Brain Health Management BrainScape Medical, a Geneva-based life sciences startup supported by&#8230;</p>
<p>The post <a href="https://bioalps.org/three-geneva-based-startups-receive-funding-from-the-fongit-innovation-fund-fif/">Three Geneva-based startups receive funding from the FONGIT Innovation Fund (FIF)</a> appeared first on <a href="https://bioalps.org">BioAlps</a>.</p>
]]></description>
										<content:encoded><![CDATA[<img width="768" height="477" src="https://bioalps.org/app/uploads/2025/04/EarlySight-768x477-1.png" class="attachment-large size-large wp-post-image" alt="" style="float:left; margin:0 15px 15px 0;" decoding="async" loading="lazy" srcset="https://bioalps.org/app/uploads/2025/04/EarlySight-768x477-1.png 768w, https://bioalps.org/app/uploads/2025/04/EarlySight-768x477-1-300x186.png 300w" sizes="auto, (max-width: 768px) 100vw, 768px" /><h2>Three life sciences projects from Geneva have been awarded funding through the FONGIT Innovation Fund (FIF), underscoring the canton’s strong commitment to driving innovation and advancing sustainable solutions.</h2>
<p>&nbsp;</p>
<p>&nbsp;</p>
<h4>CHF 100,000 FIF Seed Loan awarded to BrainScape Medical: Creating Solutions for Optimised Brain Health Management</h4>
<p><a href="https://www.brainscape-medical.com/" target="_blank" rel="noopener">BrainScape Medical</a>, a Geneva-based life sciences startup supported by the Wyss Center and led by CEO &amp; co-founder Laura Johnson, PhD, has been granted a FIF Seed Loan of CHF 100,000. The company is developing an end-to-end solution to solve the many problems of current brain disorder management and care. Their technology focuses on providing brain monitoring options designed for easy, patient-friendly, and long-term use outside the clinic. This funding will support the further development and clinical validation of their innovative solutions.</p>
<p>&nbsp;</p>
<h4>CHF 50,000 FIF Grant awarded to AnimalCare Engineering: Revolutionizing Pet Health Monitoring</h4>
<p><a href="https://animalcareengineering.com/" target="_blank" rel="noopener">AnimalCare Engineering</a> has received a FIF Grant of CHF 50,000 to advance its mission of enhancing pet health through innovative monitoring technologies. This life sciences project, supported by CERN Venture Connect and led by co-founders Anna Kolano, PhD and Katarzyna Stachyra, MEng, is developing cutting-edge devices that provide real-time health insights for pets, empowering veterinarians and pet owners to ensure optimal care. This grant will facilitate the refinement and testing of their health monitoring systems, notably for diabetes diagnosis in pets.</p>
<p>&nbsp;</p>
<h4>CHF 400,000 FIF Growth Loan awarded to EarlySight: Advancing Retinal Disease Diagnostics</h4>
<p><a href="https://www.earlysight.com/" target="_blank" rel="noopener">EarlySight</a>, an EPFL spin-off based in Geneva led by CEO Timothé Laforest, has been granted a FIF Growth Loan of CHF 400,000 after having previously been awarded a CHF 100,000 FIF Seed Loan in 2023. This life sciences startup is pioneering a novel imaging technology that enables single-cell level visualization of the retina, facilitating early detection and monitoring of retinal diseases such as age-related macular degeneration and glaucoma. This funding will support the scaling of their technology and expansion into new markets.</p>
<p>&nbsp;</p>
<h4>About the FONGIT Innovation Fund (FIF)</h4>
<p>The FIF supports innovative startups and scale-ups in the Canton of Geneva that are actively working towards the United Nations Sustainable Development Goals (SDGs). Entrepreneurs can apply for three types of financing: the FIF Grant (up to CHF 50,000), the FIF Seed Loan (up to CHF 100,000), and the FIF Growth Loan (up to CHF 400,000).</p>
<p>The next FIF application deadline is 21 May. <a href="https://www.fongit.ch/financing" target="_blank" rel="noopener">Learn more and apply at</a>.</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p><strong>Source: press release<br />
<img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4f8.png" alt="📸" class="wp-smiley" style="height: 1em; max-height: 1em;" />:EarlySight: Mathieu Kunzi, CTO &amp; Co-founder, and Timothé Laforest, CEO &amp; Co-founder</strong></p>
<p>The post <a href="https://bioalps.org/three-geneva-based-startups-receive-funding-from-the-fongit-innovation-fund-fif/">Three Geneva-based startups receive funding from the FONGIT Innovation Fund (FIF)</a> appeared first on <a href="https://bioalps.org">BioAlps</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Clee Medical receives CHF 150&#8217;000 from Venture Kick to develop a new era of highly targeted neurotherapies</title>
		<link>https://bioalps.org/clee-medical-receives-150000-from-venture-kick/</link>
		
		<dc:creator><![CDATA[Muana Minkoué]]></dc:creator>
		<pubDate>Fri, 21 Mar 2025 08:10:18 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Funding]]></category>
		<category><![CDATA[Life Sciences]]></category>
		<guid isPermaLink="false">https://bioalps.org/?p=33011</guid>

					<description><![CDATA[<p><img width="768" height="477" src="https://bioalps.org/app/uploads/2024/08/Clee-Medical.png" class="attachment-large size-large wp-post-image" alt="Clee Medical" style="float:left; margin:0 15px 15px 0;" decoding="async" loading="lazy" srcset="https://bioalps.org/app/uploads/2024/08/Clee-Medical.png 768w, https://bioalps.org/app/uploads/2024/08/Clee-Medical-300x186.png 300w" sizes="auto, (max-width: 768px) 100vw, 768px" />Addressing the challenges of precision and efficiency in brain surgery, the Wyss Center Spin-Off Clee Medical is developing technology that enhances neurosurgical procedures through advanced imaging and AI-driven guidance. The startup was financed with CHF 150,000 by Venture Kick, winning the third stage of the program. &#160; &#160; Current neurosurgical procedures face significant hurdles due&#8230;</p>
<p>The post <a href="https://bioalps.org/clee-medical-receives-150000-from-venture-kick/">Clee Medical receives CHF 150&#8217;000 from Venture Kick to develop a new era of highly targeted neurotherapies</a> appeared first on <a href="https://bioalps.org">BioAlps</a>.</p>
]]></description>
										<content:encoded><![CDATA[<img width="768" height="477" src="https://bioalps.org/app/uploads/2024/08/Clee-Medical.png" class="attachment-large size-large wp-post-image" alt="Clee Medical" style="float:left; margin:0 15px 15px 0;" decoding="async" loading="lazy" srcset="https://bioalps.org/app/uploads/2024/08/Clee-Medical.png 768w, https://bioalps.org/app/uploads/2024/08/Clee-Medical-300x186.png 300w" sizes="auto, (max-width: 768px) 100vw, 768px" /><h2>Addressing the challenges of precision and efficiency in brain surgery, the Wyss Center Spin-Off Clee Medical is developing technology that enhances neurosurgical procedures through advanced imaging and AI-driven guidance. The startup was financed with CHF 150,000 by Venture Kick, winning the third stage of the program.</h2>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>Current neurosurgical procedures face significant hurdles due to limitations in precision imaging and real-time surgical guidance. These challenges not only affect surgical efficiency but also restrict patient outcomes and slow the integration of innovative neurotechnologies.</p>
<p>The Geneva Wyss Center spin-off Clee Medical addresses these critical issues by developing innovative imaging and sensing technology and AI-driven navigation technology that delivers ultra-high-resolution, real-time visualization of the brain during surgery, without the need for contrast agents or radiation. Offering 300,000 more voxels per unit volume than MRI, this technology integrates with existing neurosurgical equipment and can be easily incorporated into current surgical routines.</p>
<p>Targeting a global market valued at CHF 2.2 billion, Clee Medical is poised to redefine stereotactic and functional neurosurgery. With prestigious medical centers as key clients, the company’s technology promises unprecedented accuracy, reduced surgical risk, increased operating capacity, and broader treatment possibilities. The Venture Kick funding will enable Clee Medical to strengthen collaborations with leading neurosurgeons and institutions, expedite early adopter engagement, and swiftly advance toward a first-in-human clinical trial milestone.</p>
<p>Clee Medical was co-founded by Matt Lapinski, an accomplished entrepreneur with over a decade of success in Boston’s dynamic medical device industry, and Dr. Abed Hammoud, a veteran innovator with 30+ years of leadership experience in stereotactic neurosurgery and technology ventures.</p>
<p>“The Venture Kick process has represented a substantial part of our journey, providing funding, strategic guidance, and access to an incredible network of entrepreneurs and experts,” commented Matthew Lapinski, CEO and Co-Founder of Clee Medical. “We are truly grateful for the opportunity and support that have helped us refine our vision and accelerate our impact. We are excited to continue and apply our learnings from the Venture Kick process to improve minimally invasive brain surgery worldwide!”</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>Source: press release<br />
<img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4f8.png" alt="📸" class="wp-smiley" style="height: 1em; max-height: 1em;" /> Matthew Lapinski (left) and Abed Hammoud (right), co-founders of Clee Medical. © Clee Medical.</p>
<p>The post <a href="https://bioalps.org/clee-medical-receives-150000-from-venture-kick/">Clee Medical receives CHF 150&#8217;000 from Venture Kick to develop a new era of highly targeted neurotherapies</a> appeared first on <a href="https://bioalps.org">BioAlps</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Two Geneva-based startups and projects get fundings by FONGIT</title>
		<link>https://bioalps.org/fif-select-new-stratup-projects/</link>
		
		<dc:creator><![CDATA[Muana Minkoué]]></dc:creator>
		<pubDate>Fri, 07 Mar 2025 10:16:41 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Funding]]></category>
		<category><![CDATA[Innovation]]></category>
		<category><![CDATA[Life Sciences]]></category>
		<guid isPermaLink="false">https://bioalps.org/?p=32954</guid>

					<description><![CDATA[<p><img width="768" height="477" src="https://bioalps.org/app/uploads/2025/03/FONGIT-alexandre.png" class="attachment-large size-large wp-post-image" alt="" style="float:left; margin:0 15px 15px 0;" decoding="async" loading="lazy" srcset="https://bioalps.org/app/uploads/2025/03/FONGIT-alexandre.png 768w, https://bioalps.org/app/uploads/2025/03/FONGIT-alexandre-300x186.png 300w" sizes="auto, (max-width: 768px) 100vw, 768px" />&#8220;Patient-specific post-operative orthoses for hallux valgus&#8221; project and Immitra Bio GmbH have been selected to receive funding through the FONGIT Innovation Fund (FIF), aimed at fostering innovation and advancing sustainable solutions in the Canton of Geneva. &#160; &#160; CHF 50,000 FIF Grant awarded to &#8220;Patient-specific post-operative orthoses for hallux valgus&#8221; project Led by engineer Alexandre&#8230;</p>
<p>The post <a href="https://bioalps.org/fif-select-new-stratup-projects/">Two Geneva-based startups and projects get fundings by FONGIT</a> appeared first on <a href="https://bioalps.org">BioAlps</a>.</p>
]]></description>
										<content:encoded><![CDATA[<img width="768" height="477" src="https://bioalps.org/app/uploads/2025/03/FONGIT-alexandre.png" class="attachment-large size-large wp-post-image" alt="" style="float:left; margin:0 15px 15px 0;" decoding="async" loading="lazy" srcset="https://bioalps.org/app/uploads/2025/03/FONGIT-alexandre.png 768w, https://bioalps.org/app/uploads/2025/03/FONGIT-alexandre-300x186.png 300w" sizes="auto, (max-width: 768px) 100vw, 768px" /><h2>&#8220;Patient-specific post-operative orthoses for hallux valgus&#8221; project and Immitra Bio GmbH have been selected to receive funding through the FONGIT Innovation Fund (FIF), aimed at fostering innovation and advancing sustainable solutions in the Canton of Geneva.</h2>
<p>&nbsp;</p>
<p>&nbsp;</p>
<h4>CHF 50,000 FIF Grant awarded to &#8220;Patient-specific post-operative orthoses for hallux valgus&#8221; project</h4>
<p>Led by engineer Alexandre Saconney-Pfister in collaboration with the Centre Assal research team, the project &#8220;Patient-specific post-operative orthoses for hallux valgus,&#8221; initiated by Dr. Victor Dubois-Ferrière, aims to optimize post-operative care to improve clinical outcomes.<br />
Thanks to 3D printing, these orthoses simplify hospital care while ensuring better patient comfort throughout the healing process. The project is supported by the Forte Foundation, and the FIF grant will enable the project to further advance in its development.</p>
<p>&nbsp;</p>
<h4>CHF 100,000 FIF Seed Loan awarded to Immitra Bio GmbH: Advancing Genetic Therapies for Rare Diseases</h4>
<p>ETHZ spin-off Immitra Bio is pioneering genetic medicine to develop transformative treatments for rare diseases by combining hematopoietic stem cells (HSCs) with CRISPR-Cas9 gene editing. Their proprietary HematoGen platform enables precise and durable gene modifications within blood stem cells, addressing the root causes of genetic disorders. Immitra Bio is led by CEO and co-founder Jan Nelis, with a team dedicated to unlocking the potential of genetic cures. The company plans to move their headquarters to Geneva.<br />
The FIF Seed Loan will support this startup in advancing its efforts to treat rare diseases while also fostering new collaborations with Geneva’s world-class research institutes in this field.</p>
<h4></h4>
<h4>About the FONGIT Innovation Fund (FIF)</h4>
<p>The FIF supports innovative startups and scale-ups in the Canton of Geneva that are actively working towards the United Nations Sustainable Development Goals (SDGs). Entrepreneurs can apply for three types of financing: the FIF Grant (up to CHF 50,000), the FIF Seed Loan (up to CHF 100,000), and the FIF Growth Loan (up to CHF 400,000).<br />
The FIF is supported by the State of Geneva, the Fondation Genevoise pour l’Innovation Technologique (FONGIT), the Modus Foundation, the United Nations International Trade Center (ITC) and the United Nations Environment Agency.</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p><strong>Source: press release</strong></p>
<p><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4f7.png" alt="📷" class="wp-smiley" style="height: 1em; max-height: 1em;" />: Alexandre Saconney-Pfister &amp; Dr Victor Dubois-Ferrière</p>
<p>The post <a href="https://bioalps.org/fif-select-new-stratup-projects/">Two Geneva-based startups and projects get fundings by FONGIT</a> appeared first on <a href="https://bioalps.org">BioAlps</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Neurosoft Bioelectronics sets record for most electrodes in a soft and stretchable brain interface tested in a human</title>
		<link>https://bioalps.org/neurosoft-bioelectronics-sets-new-record/</link>
		
		<dc:creator><![CDATA[Muana Minkoué]]></dc:creator>
		<pubDate>Thu, 27 Feb 2025 15:02:34 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Innovation]]></category>
		<category><![CDATA[Life Sciences]]></category>
		<category><![CDATA[Neurology]]></category>
		<guid isPermaLink="false">https://bioalps.org/?p=32894</guid>

					<description><![CDATA[<p><img width="768" height="477" src="https://bioalps.org/app/uploads/2025/02/Neurosoft-record.png" class="attachment-large size-large wp-post-image" alt="Neurosoft-record" style="float:left; margin:0 15px 15px 0;" decoding="async" loading="lazy" srcset="https://bioalps.org/app/uploads/2025/02/Neurosoft-record.png 768w, https://bioalps.org/app/uploads/2025/02/Neurosoft-record-300x186.png 300w" sizes="auto, (max-width: 768px) 100vw, 768px" />Neurosoft Bioelectronics SA, a Swiss neurotechnology startup based at Campus Biotech in Geneva, has achieved a major milestone with the successful testing of its high channel count brain interface in the first two human patients. &#160; &#160; This milestone was reached in February 2025 at University Medical Center (UMC) Utrecht, where a team led by&#8230;</p>
<p>The post <a href="https://bioalps.org/neurosoft-bioelectronics-sets-new-record/">Neurosoft Bioelectronics sets record for most electrodes in a soft and stretchable brain interface tested in a human</a> appeared first on <a href="https://bioalps.org">BioAlps</a>.</p>
]]></description>
										<content:encoded><![CDATA[<img width="768" height="477" src="https://bioalps.org/app/uploads/2025/02/Neurosoft-record.png" class="attachment-large size-large wp-post-image" alt="Neurosoft-record" style="float:left; margin:0 15px 15px 0;" decoding="async" loading="lazy" srcset="https://bioalps.org/app/uploads/2025/02/Neurosoft-record.png 768w, https://bioalps.org/app/uploads/2025/02/Neurosoft-record-300x186.png 300w" sizes="auto, (max-width: 768px) 100vw, 768px" /><h2>Neurosoft Bioelectronics SA, a Swiss neurotechnology startup based at Campus Biotech in Geneva, has achieved a major milestone with the successful testing of its high channel count brain interface in the first two human patients.</h2>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>This milestone was reached in February 2025 at University Medical Center (UMC) Utrecht, where a team led by Professor Maeike Zijlmans employed the device during epilepsy surgery.<br />
This novel brain interface is designed to detect key epilepsy biomarkers &#8211; high-frequency oscillations and fast ripples &#8211; allowing surgeons to identify epileptic tissue with unprecedented precision during the procedure.</p>
<p>With 64 sensing channels embedded in a stretchable material that is 1&#8217;000 to 100&#8217;000 times softer than conventional electrodes, the device conforms seamlessly to the brain&#8217;s surface. This softness improves comformability with the brain, while ensuring high-resolution neural recordings, helping neurosurgeons distinguish between healthy and epileptic tissue more accurately, thereby reducing the risk of either excessive or insufficient tissue removal.</p>
<p>&#8220;We are pushing the frontier of neurotechnology focusing on materials that are intended to interface seamlessly with the brain,&#8221; said Nicolas Vachicouras, CEO and co-founder of Neurosoft Bioelectronics. &#8220;This milestone solidifies our leadership in soft, stretchable brain interfaces and paves the way for broader applications in neuroprosthetics and brain-computer interfaces.&#8221;</p>
<p>&#8220;The Neurosoft flexible grid has been developed according to our clinical needs. The flexibility can be especially useful for recording small epileptic activity, like high frequency oscillations and for checking the surgical borders after initial tissue resection.&#8221; said Prof. Maeike Zijlmans, epilepsy specialist at UMC Utrecht.</p>
<p>These first two successful trials mark the beginning of a larger, 12-patient study at UMC Utrecht, designed to validate the technology for broader clinical use. The ultimate goal is to secure European regulatory approval and make this high-resolution technology available to epilepsy surgery centers across Europe.</p>
<p>The success of this initiative is the result of close collaboration between Neurosoft Bioelectronics and UMC Utrecht, demonstrating how startups and hospitals can work together to bring cutting-edge medical technologies into real-world clinical settings.</p>
<p>This work has been made possible through the support of the Wyss Center for Bio and Neuroengineering, which has played a key role in fostering Neurosoft Bioelectronics’ technological and clinical advancements. Additionally, the study conducted at UMC Utrecht is funded by the European Research Council (ERC), reflecting the project&#8217;s significance in advancing neurotechnology and epilepsy research.</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>Source: press release</p>
<p>The post <a href="https://bioalps.org/neurosoft-bioelectronics-sets-new-record/">Neurosoft Bioelectronics sets record for most electrodes in a soft and stretchable brain interface tested in a human</a> appeared first on <a href="https://bioalps.org">BioAlps</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>BioAlps Industry Award Nomination 2025</title>
		<link>https://bioalps.org/bioalps-awards-nomination-2025/</link>
		
		<dc:creator><![CDATA[Muana Minkoué]]></dc:creator>
		<pubDate>Mon, 10 Feb 2025 15:19:17 +0000</pubDate>
				<category><![CDATA[Non classé]]></category>
		<guid isPermaLink="false">https://bioalps.org/?p=32664</guid>

					<description><![CDATA[<p><img width="768" height="477" src="https://bioalps.org/app/uploads/2025/02/BND-2025-STD-website.png" class="attachment-large size-large wp-post-image" alt="BND 2025 STD website" style="float:left; margin:0 15px 15px 0;" decoding="async" loading="lazy" srcset="https://bioalps.org/app/uploads/2025/02/BND-2025-STD-website.png 768w, https://bioalps.org/app/uploads/2025/02/BND-2025-STD-website-300x186.png 300w" sizes="auto, (max-width: 768px) 100vw, 768px" />Merci de bien vouloir remplir ce formulaire pour indiquer l&#8217;entreprise que vous souhaitez nommer pour le BioAlps Industry Award 2025 qui sera remis le 11 novembre 2025 au Théâtre du Crochetan à Monthey lors du BioAlps Networking Day. Les nominations seront évaluées selon les critères suivants : impact économique, intégration dans le réseau, investissement, nombre&#8230;</p>
<p>The post <a href="https://bioalps.org/bioalps-awards-nomination-2025/">BioAlps Industry Award Nomination 2025</a> appeared first on <a href="https://bioalps.org">BioAlps</a>.</p>
]]></description>
										<content:encoded><![CDATA[<img width="768" height="477" src="https://bioalps.org/app/uploads/2025/02/BND-2025-STD-website.png" class="attachment-large size-large wp-post-image" alt="BND 2025 STD website" style="float:left; margin:0 15px 15px 0;" decoding="async" loading="lazy" srcset="https://bioalps.org/app/uploads/2025/02/BND-2025-STD-website.png 768w, https://bioalps.org/app/uploads/2025/02/BND-2025-STD-website-300x186.png 300w" sizes="auto, (max-width: 768px) 100vw, 768px" /><p>Merci de bien vouloir remplir ce formulaire pour indiquer l&#8217;entreprise que vous souhaitez nommer pour le BioAlps Industry Award 2025 qui sera remis le 11 novembre 2025 au Théâtre du Crochetan à Monthey lors du BioAlps Networking Day.</p>
<p>Les nominations seront évaluées selon les critères suivants : impact économique, intégration dans le réseau, investissement, nombre d’emplois créés, et contribution au rayonnement de la Suisse.</p>
<p>⚠️ Si vous souhaitez nominer plusieurs entreprises, merci de remplir un formulaire par société.</p>
<p>Liste des précédents lauréats:</p>
<p>2009 – DEBIOPHARM SA<br />
2010 – BIOCARTIS SA<br />
2011 – NESTLE SA<br />
2012 – UCB FARCHIM SA<br />
2013 – AC IMMUNE SA<br />
2014 – CSL BEHRING AG<br />
2015 – CELGENE International SA<br />
2016 – LONZA AG<br />
2017 – VIFOR PHARMA (FR &amp; GE)<br />
2018 – MEDTRONIC TOLOCHENAZ<br />
2019 – FERRING PHARMACEUTICALS<br />
2021 – SOPHiA GENETICS<br />
2022 – INCYTE<br />
2023 – SELEXIS<br />
2024 – TAKEDA</p>
<p>&nbsp;</p>
<p><script>
var gform;gform||(document.addEventListener("gform_main_scripts_loaded",function(){gform.scriptsLoaded=!0}),document.addEventListener("gform/theme/scripts_loaded",function(){gform.themeScriptsLoaded=!0}),window.addEventListener("DOMContentLoaded",function(){gform.domLoaded=!0}),gform={domLoaded:!1,scriptsLoaded:!1,themeScriptsLoaded:!1,isFormEditor:()=>"function"==typeof InitializeEditor,callIfLoaded:function(o){return!(!gform.domLoaded||!gform.scriptsLoaded||!gform.themeScriptsLoaded&&!gform.isFormEditor()||(gform.isFormEditor()&&console.warn("The use of gform.initializeOnLoaded() is deprecated in the form editor context and will be removed in Gravity Forms 3.1."),o(),0))},initializeOnLoaded:function(o){gform.callIfLoaded(o)||(document.addEventListener("gform_main_scripts_loaded",()=>{gform.scriptsLoaded=!0,gform.callIfLoaded(o)}),document.addEventListener("gform/theme/scripts_loaded",()=>{gform.themeScriptsLoaded=!0,gform.callIfLoaded(o)}),window.addEventListener("DOMContentLoaded",()=>{gform.domLoaded=!0,gform.callIfLoaded(o)}))},hooks:{action:{},filter:{}},addAction:function(o,r,e,t){gform.addHook("action",o,r,e,t)},addFilter:function(o,r,e,t){gform.addHook("filter",o,r,e,t)},doAction:function(o){gform.doHook("action",o,arguments)},applyFilters:function(o){return gform.doHook("filter",o,arguments)},removeAction:function(o,r){gform.removeHook("action",o,r)},removeFilter:function(o,r,e){gform.removeHook("filter",o,r,e)},addHook:function(o,r,e,t,n){null==gform.hooks[o][r]&&(gform.hooks[o][r]=[]);var d=gform.hooks[o][r];null==n&&(n=r+"_"+d.length),gform.hooks[o][r].push({tag:n,callable:e,priority:t=null==t?10:t})},doHook:function(r,o,e){var t;if(e=Array.prototype.slice.call(e,1),null!=gform.hooks[r][o]&&((o=gform.hooks[r][o]).sort(function(o,r){return o.priority-r.priority}),o.forEach(function(o){"function"!=typeof(t=o.callable)&&(t=window[t]),"action"==r?t.apply(null,e):e[0]=t.apply(null,e)})),"filter"==r)return e[0]},removeHook:function(o,r,t,n){var e;null!=gform.hooks[o][r]&&(e=(e=gform.hooks[o][r]).filter(function(o,r,e){return!!(null!=n&&n!=o.tag||null!=t&&t!=o.priority)}),gform.hooks[o][r]=e)}});
</script>

                <div class='gf_browser_safari gf_browser_iphone gform_wrapper gravity-theme gform-theme--no-framework' data-form-theme='gravity-theme' data-form-index='0' id='gform_wrapper_14' >
                        <div class='gform_heading'>
                            <h2 class="gform_title">BioAlps Awards 2025</h2>
                            <p class='gform_description'></p>
                        </div><form method='post' enctype='multipart/form-data'  id='gform_14'  action='/author/muana/feed/' data-formid='14' novalidate>
                        <div class='gform-body gform_body'><div id='gform_fields_14' class='gform_fields top_label form_sublabel_below description_below validation_below'><div id="field_14_4" class="gfield gfield--type-post_custom_field gfield--input-type-text gfield--width-full gfield_contains_required field_sublabel_below gfield--no-description field_description_below field_validation_below gfield_visibility_visible"  ><label class='gfield_label gform-field-label' for='input_14_4'>Nom de l&#039;Office de Promotion économique<span class="gfield_required"><span class="gfield_required gfield_required_text">(Required)</span></span></label><div class='ginput_container ginput_container_text'><input name='input_4' id='input_14_4' type='text' value='' class='large'     aria-required="true" aria-invalid="false"   /></div></div><div id="field_14_7" class="gfield gfield--type-post_custom_field gfield--input-type-text gfield--width-third gfield_contains_required field_sublabel_below gfield--no-description field_description_below field_validation_below gfield_visibility_visible"  ><label class='gfield_label gform-field-label' for='input_14_7'>Personne de contact<span class="gfield_required"><span class="gfield_required gfield_required_text">(Required)</span></span></label><div class='ginput_container ginput_container_text'><input name='input_7' id='input_14_7' type='text' value='' class='large'     aria-required="true" aria-invalid="false"   /></div></div><div id="field_14_30" class="gfield gfield--type-post_custom_field gfield--input-type-text gfield--width-third gfield_contains_required field_sublabel_below gfield--no-description field_description_below field_validation_below gfield_visibility_visible"  ><label class='gfield_label gform-field-label' for='input_14_30'>Email<span class="gfield_required"><span class="gfield_required gfield_required_text">(Required)</span></span></label><div class='ginput_container ginput_container_text'><input name='input_30' id='input_14_30' type='text' value='' class='large'     aria-required="true" aria-invalid="false"   /></div></div><div id="field_14_6" class="gfield gfield--type-post_custom_field gfield--input-type-text gfield--width-third gfield_contains_required field_sublabel_below gfield--no-description field_description_below field_validation_below gfield_visibility_visible"  ><label class='gfield_label gform-field-label' for='input_14_6'>Téléphone<span class="gfield_required"><span class="gfield_required gfield_required_text">(Required)</span></span></label><div class='ginput_container ginput_container_text'><input name='input_6' id='input_14_6' type='text' value='' class='large'     aria-required="true" aria-invalid="false"   /></div></div><div id="field_14_32" class="gfield gfield--type-post_custom_field gfield--input-type-text gfield--width-full gfield_contains_required field_sublabel_below gfield--no-description field_description_below field_validation_below gfield_visibility_visible"  ><label class='gfield_label gform-field-label' for='input_14_32'>Nom de l&#039;entreprise nominée<span class="gfield_required"><span class="gfield_required gfield_required_text">(Required)</span></span></label><div class='ginput_container ginput_container_text'><input name='input_32' id='input_14_32' type='text' value='' class='large'     aria-required="true" aria-invalid="false"   /></div></div><div id="field_14_33" class="gfield gfield--type-post_custom_field gfield--input-type-text gfield--width-full gfield_contains_required field_sublabel_below gfield--no-description field_description_below field_validation_below gfield_visibility_visible"  ><label class='gfield_label gform-field-label' for='input_14_33'>Secteur d&#039;activité<span class="gfield_required"><span class="gfield_required gfield_required_text">(Required)</span></span></label><div class='ginput_container ginput_container_text'><input name='input_33' id='input_14_33' type='text' value='' class='large'     aria-required="true" aria-invalid="false"   /></div></div><div id="field_14_14" class="gfield gfield--type-post_custom_field gfield--input-type-textarea gfield--width-full gfield_contains_required field_sublabel_below gfield--no-description field_description_below field_validation_below gfield_visibility_visible"  ><label class='gfield_label gform-field-label' for='input_14_14'>IMPACT ECONOMIQUE (chiffre d’affaires, impact sur le PIB, partenariats stratégiques...)<span class="gfield_required"><span class="gfield_required gfield_required_text">(Required)</span></span></label><div class='ginput_container ginput_container_textarea'><textarea name='input_14' id='input_14_14' class='textarea large'   maxlength='1000'  aria-required="true" aria-invalid="false"   rows='10' cols='50'></textarea></div></div><div id="field_14_34" class="gfield gfield--type-post_custom_field gfield--input-type-textarea gfield--width-full gfield_contains_required field_sublabel_below gfield--no-description field_description_below field_validation_below gfield_visibility_visible"  ><label class='gfield_label gform-field-label' for='input_14_34'>INTEGRATION DANS LE REGION (Collaboration locales, engagements au sein des clusters ou associations sectorielles...)<span class="gfield_required"><span class="gfield_required gfield_required_text">(Required)</span></span></label><div class='ginput_container ginput_container_textarea'><textarea name='input_34' id='input_14_34' class='textarea large'   maxlength='1000'  aria-required="true" aria-invalid="false"   rows='10' cols='50'></textarea></div></div><div id="field_14_35" class="gfield gfield--type-post_custom_field gfield--input-type-textarea gfield--width-full gfield_contains_required field_sublabel_below gfield--no-description field_description_below field_validation_below gfield_visibility_visible"  ><label class='gfield_label gform-field-label' for='input_14_35'>INVESTISSEMENT ( ex. nouveaux projets, innovations technologiques, ou infrastructures...)<span class="gfield_required"><span class="gfield_required gfield_required_text">(Required)</span></span></label><div class='ginput_container ginput_container_textarea'><textarea name='input_35' id='input_14_35' class='textarea large'   maxlength='1000'  aria-required="true" aria-invalid="false"   rows='10' cols='50'></textarea></div></div><div id="field_14_36" class="gfield gfield--type-post_custom_field gfield--input-type-textarea gfield--width-full gfield_contains_required field_sublabel_below gfield--no-description field_description_below field_validation_below gfield_visibility_visible"  ><label class='gfield_label gform-field-label' for='input_14_36'>NB D&#039;EMPLOIS CREES (ex. nombre d’emplois directs/indirects créés dans les 3 dernières années...)<span class="gfield_required"><span class="gfield_required gfield_required_text">(Required)</span></span></label><div class='ginput_container ginput_container_textarea'><textarea name='input_36' id='input_14_36' class='textarea large'   maxlength='1000'  aria-required="true" aria-invalid="false"   rows='10' cols='50'></textarea></div></div><div id="field_14_37" class="gfield gfield--type-post_custom_field gfield--input-type-textarea gfield--width-full gfield_contains_required field_sublabel_below gfield--no-description field_description_below field_validation_below gfield_visibility_visible"  ><label class='gfield_label gform-field-label' for='input_14_37'>RAYONNEMENT DE LA SUISSE (ex. réputation internationale, exportations, participation à des salons ou conférences mondiales...)<span class="gfield_required"><span class="gfield_required gfield_required_text">(Required)</span></span></label><div class='ginput_container ginput_container_textarea'><textarea name='input_37' id='input_14_37' class='textarea large'   maxlength='1000'  aria-required="true" aria-invalid="false"   rows='10' cols='50'></textarea></div></div><div id="field_14_38" class="gfield gfield--type-post_custom_field gfield--input-type-textarea gfield--width-full field_sublabel_below gfield--has-description field_description_below field_validation_below gfield_visibility_visible"  ><label class='gfield_label gform-field-label' for='input_14_38'>Commentaires ou remarques supplémentaires</label><div class='ginput_container ginput_container_textarea'><textarea name='input_38' id='input_14_38' class='textarea large'  aria-describedby="gfield_description_14_38" maxlength='1000'   aria-invalid="false"   rows='10' cols='50'></textarea></div><div class='gfield_description' id='gfield_description_14_38'>Si vous souhaitez ajouter des observations générales ou d’autres critères non mentionnés, merci de les indiquer ici</div></div><fieldset id="field_14_26" class="gfield gfield--type-consent gfield--type-choice gfield--input-type-consent gfield--width-full gfield_contains_required field_sublabel_below gfield--has-description field_description_below field_validation_below gfield_visibility_visible"  ><legend class='gfield_label gform-field-label gfield_label_before_complex' >Consent<span class="gfield_required"><span class="gfield_required gfield_required_text">(Required)</span></span></legend><div class='ginput_container ginput_container_consent'><input name='input_26.1' id='input_14_26_1' type='checkbox' value='1'  aria-describedby="gfield_consent_description_14_26" aria-required="true" aria-invalid="false"   /> <label class="gform-field-label gform-field-label--type-inline gfield_consent_label" for='input_14_26_1' >I consent to my submitted data being collected and stored as outlined by our privacy policy</label><input type='hidden' name='input_26.2' value='I consent to my submitted data being collected and stored as outlined by our privacy policy' class='gform_hidden' /><input type='hidden' name='input_26.3' value='9' class='gform_hidden' /></div><div class='gfield_description gfield_consent_description' id='gfield_consent_description_14_26' tabindex='0'>1. About BioAlps Association<br />
Founded in 2003, BioAlps Association empowers the Swiss Health Valley and represents the Western Switzerland Life Sciences ecosystem (medtech, biotech, pharma, digital health, nutrition, cosmetics, and more). The organisation is supported by 7 cantons: Bern, Fribourg, Vaud, Neuchâtel, Geneva, Valais and Jura, by the Swiss State Secretariat for Economic Affairs (SECO) and by 15 academic institutions. Through the organization and support of numerous events in Switzerland and internationally, as well as through regular publications, BioAlps offers opportunities for synergies within the life sciences community to representatives of academia, industry, finance, politics and media.<br />
BioAlps Association Secretary General is located at Avenue de Sécheron 15, 1202 Geneva, Switzerland. We can be reached by phone at +41 22 545 12 91 or by email: cont&#97;&#99;&#116;&#64;&#98;&#105;&#111;&#x61;&#x6c;&#x70;&#x73;&#x2e;&#x6f;&#x72;&#x67;. <br />
 <br />
2. BioAlps Association Privacy Statement<br />
The purpose of this Privacy Policy is to inform you of the procedures regarding the collection, use and disclosure of information on BioAlps Association website, including any mobile versions or related mobile applications, collectively called BioAlps Association Sites.<br />
<br />
BioAlps Association website (hereinafter: the “Site”) is provided by BioAlps Association and/or its affiliates. By visiting BioAlps Association Sites and providing information to BioAlps Association, you acknowledge that you have been informed and you consent to the Privacy Policy, including with regard the use and disclosure of personal information which may be collected when you contact BioAlps Association, subscribe to BioAlps Association email alerts and newsletters, when you register for events, trainings or on a platforms, or when you request any other products and services provided by BioAlps Association in BioAlps Association with the purposes detailed in section 4. If you do not wish your personal information to be used by BioAlps Association in the manner set out in this Privacy Policy, please do not provide us this information.<br />
<br />
3. Nature of information collected<br />
3.1. Personal data that you provide voluntarily or that we receive through referrals<br />
In order to receive BioAlps Association newsletters or information about BioAlps Association products and services, to contact BioAlps Association for any questions or comments, to request BioAlps Association products and services, or to register for BioAlps Association events, trainings or plateforms, you may choose to provide some personal information.<br />
<br />
The categories of personal information that BioAlps Association may collect for the processing purposes described hereto are:<br />
<br />
Identification data such as family name, first name;<br />
Demographic data such as country of residence;<br />
Professional data such as organization, job title, activity, main area of interest;<br />
Contact data such as, email address and mobile phone number.<br />
<br />
BioAlps Association will ensure that personal data collected from you is strictly necessary for the purposes described in section 4 below.<br />
<br />
3.2. Personal data that we collect automatically<br />
When you visit our website or open our newsalerts or newsletters, we may collect certain information automatically from your device. In some countries, including countries in the European Economic Area (“EEA”), this information may be considered Personal Data under Applicable Data Protection Laws.<br />
<br />
Specifically, the information we collect automatically may include information like your IP address, device type, unique device identification numbers, browser-type, broad geographic location (e.g. country or city-level location) and other technical information. We may also collect information about how your device has interacted with our Website, including the pages accessed and links clicked.<br />
<br />
Collecting this information enables us to better understand the visitors who come to our website, where they come from, and what content on our website is of interest to them. We use this information for our internal analytics purposes and to improve the quality and relevance of our website to our visitors.<br />
<br />
Some of this information may be collected using cookies and similar tracking technology, as explained in section 9 below.<br />
<br />
4. Purposes of Data Processing<br />
The BioAlps Association will only use your personal data where permitted to do so by applicable law. Under GDPR, the processing is lawful only if and to the extent that one of the following legal basis applies: <br />
<br />
Consent: you have given consent to our use of your information. You may withdraw your consent through an unsubscribe link.<br />
Contract performance: your information is necessary to enter into or perform a contract with you.<br />
Legal obligation: your information is necessary to comply with our legal obligations<br />
Legitimate interests: your information is necessary to pursue a legitimate interest<br />
 <br />
<br />
Our legal basis for collecting and using your information described below will depend on the personal data concerned and the specific contact in which we collect it.<br />
<br />
 <br />
<br />
The BioAlps Association may use the collected personal information:<br />
<br />
To manage your membership as an affiliate member of BioAlps Association. The legal basis is legitimate interests, consent or contract performance.<br />
To engage with you in BioAlps Association projects and activities. The legal basis is legitimate interests, consent or contract performance.<br />
For communication or marketing purposes – we can send news alerts, newsletters, emails, or other communications relating to products, services and events that may be of interest. We will provide an option to unsubscribe or opt out of further communications. The legal basis is legitimate interests or consent.<br />
To process and respond to your questions and/or inquiries. The legal basis is legitimate interests.<br />
For evaluation and development of BioAlps Association activities purposes – analysis in order to improve our services and offers. BioAlps Association, or third parties on its behalf, may also use information provided in an aggregate and anonymous form for internal business and planning purposes, including to analyse trends and statistics. The legal basis is legitimate interests.<br />
To facilitate use of websites or platforms. The legal basis is legitimate interests, consent or contract performance.<br />
 <br />
5. Data retention<br />
BioAlps Association will retain your personal data only for as long as it is necessary to complete the operations for which data has been collected or until you request to no longer receive communications from us, in accordance with applicable laws and regulations.<br />
<br />
When you submit an enquiry to BioAlps Association via our email &#99;o&#x6e;t&#x61;c&#x74;&#64;&#x62;i&#x6f;a&#x6c;&#112;&#x73;&#46;&#x6f;&#114;&#x67;, the details of your enquiry may be stored by BioAlps Association in our email archives. <br />
<br />
6. Security<br />
Protecting your privacy and your personal information is a priority for BioAlps Association. BioAlps Association has taken reasonable measures to protect your personal information from loss, misuse and alteration. However, please be aware that no data transmission over the Internet or storage technology can be guaranteed to be 100% secure. BioAlps Association can only take steps to help reduce the risks of unauthorized access to information/data. Each individual using the Internet user can also take steps to help protect his/her personal information and is encouraged to do so to further minimize the likelihood that a security incident may occur. <br />
<br />
7. Your rights<br />
Right to request access, rectification, erasure, restriction processing, object to the processing, portability<br />
<br />
The collected information is necessary for your registration and, more generally, for the purposes described in section 4. It is subject to data processing at BioAlps Association. In application of the French law on data protection and the European Regulation on the protection of natural persons with regard to the processing of personal data and of the free movement of such data (General Data Protection Regulation “GDPR”) you will benefit from the right to access, rectification, erasure, restriction processing, object to the processing, portability. If you wish to exercise these rights and obtain all relevant information, please contact us at &#x63;&#111;n&#x74;&#97;c&#x74;&#64;b&#x69;&#111;a&#x6c;&#112;s&#x2e;&#x6f;r&#x67;.<br />
<br />
In which circumstances can you exercise your rights with BioAlps Association?<br />
<br />
 <br />
<br />
7.1. Right of access<br />
1. You have the right to obtain from the controller, confirmation as to whether or not your personal data is being processed, and, where that is the case, access to your personal data and the following information:<br />
<br />
the purposes of the processing;<br />
the categories of personal data concerned;<br />
the recipients or categories of recipient to whom the personal data has been or will be disclosed, in particular recipients in third countries or international organisations;<br />
where possible, the envisaged period for which the personal data will be stored, or, if not possible, the criteria used to determine that period;<br />
the existence of the right to request from the controller rectification or erasure of personal data or restriction of processing of personal data concerning vi. the data subject or to object to such processing;<br />
the right to lodge a complaint with a supervisory authority;<br />
where the personal data is not collected from you, any available information as to it source;<br />
subject to the conditions provided by the GDPR, the existence of automated decision-making.<br />
2. The controller shall provide a copy of the personal data undergoing processing. For any further copies you may request, the controller may charge a reasonable fee based on administrative costs.<br />
<br />
3. The right to obtain a copy referred to in paragraph 2 shall not adversely affect the rights and freedoms of others. <br />
<br />
7.2. Right to rectification<br />
You have the right to obtain from the controller without undue delay the rectification of inaccurate personal data. Taking into account the purposes of the processing, you have the right to have incomplete personal data completed, including by means of providing a supplementary statement.<br />
<br />
 <br />
7.3. Right to erasure (‘right to be forgotten’)<br />
1. You shall have the right to obtain from the controller the erasure of personal data without undue delay and the controller shall have the obligation to erase personal data without undue delay where one of the following grounds applies:<br />
<br />
the personal data is no longer necessary in relation to the purposes for which it was collected or otherwise processed;<br />
you withdraw your consent;<br />
you object to the processing on grounds relating to your particular situation including profiling and there are no overriding legitimate grounds for the processing, or you object to the processing for direct marketing;<br />
the personal data has been unlawfully processed;<br />
the personal data has to be erased for compliance in accordance with European Union or French law.<br />
 <br />
<br />
2. Where the controller has made the personal data public and is obliged pursuant to paragraph 1 to erase the personal data, the controller, taking account of available technology and the cost of implementation, shall take reasonable steps, including technical measures, to inform controllers which are processing the personal data that you have requested the erasure by such controllers of any links to, or copy or replication of the personal data.<br />
<br />
3. The right to erasure shall not apply to the extent that processing is necessary for:<br />
<br />
exercising the right of freedom of expression and information;<br />
compliance with a legal obligation to which the controller is subject or for the performance of a task carried out in the public interest or in the exercise of official authority vested in the controller;<br />
archiving purposes in the public interest, scientific or historical research purposes or statistical purposes in so far as the right referred to in paragraph 1 is likely to render impossible or seriously impair the achievement of the objectives of that processing;<br />
the establishment, exercise or defence of legal claims.<br />
 <br />
<br />
7.4. Right to restriction of processing<br />
1. You shall have the right to obtain from the controller restriction of processing where one of the following applies:<br />
<br />
you contested the accuracy of the personal data, for a period enabling the controller to verify the accuracy of the personal data;<br />
the processing is unlawful and you oppose the erasure of the personal data and requests the restriction of its use instead;<br />
the controller no longer needs the personal data for the purposes of the processing, but it is required by you for the establishment, exercise or defence of legal claims;<br />
you have objected to processing on grounds relating to your particular situation including profiling pending the verification of whether the legitimate grounds of the controller override yours.<br />
2. Where processing has been restricted under paragraph 1, such personal data shall, with the exception of storage, only be processed with the data subject’s consent or for the establishment, exercise or defence of legal claims or for the protection of the rights of another natural or legal person or for reasons of important public interest of the European Union or of a Member State.<br />
<br />
3. When you have obtained restriction of processing pursuant to paragraph 1, you shall be informed by the controller before the restriction of processing is lifted.<br />
<br />
Notification obligation regarding rectification or erasure of personal data or restriction of processing:<br />
<br />
The controller shall communicate any rectification or erasure of personal data or restriction of processing carried out to each recipient to whom the personal data has been disclosed, unless this proves impossible or involves disproportionate effort. The controller shall inform you about those recipients if you request it.<br />
<br />
7.5. Right to data portability<br />
1. You shall have the right to receive personal data which you have provided to a controller, in a structured, commonly used and machine-readable format and have the right to transmit that data to another controller without hindrance from the controller to which the personal data has been provided, where:<br />
<br />
the processing is based on consent; and<br />
the processing is carried out by automated means.<br />
2. In exercising your right to data portability pursuant to paragraph 1, you shall have the right to have your personal data transmitted directly from one controller to another, where technically feasible.<br />
<br />
3. The exercise of your right to data portability shall be without prejudice to the right of erasure. That right shall not apply to processing necessary for the performance of a task carried out in the public interest or in the exercise of official authority vested in the controller.<br />
<br />
 4. The right to data portability shall not adversely affect the rights and freedoms of others.<br />
<br />
7.6. Right to object<br />
1. You shall have the right to object, on grounds relating to your particular situation, at any time to processing which is based on legitimate interests. The controller shall no longer process your personal data, unless the controller demonstrates compelling legitimate grounds for the processing which override your interests, rights and freedoms or for the establishment, exercise or defence of legal claims.<br />
<br />
2. Where personal data is processed for direct marketing purposes, you shall have the right to object at any time to processing of personal data for such marketing, which includes profiling to the extent that it is related to such direct marketing.<br />
<br />
3. Where you object to processing for direct marketing purposes, the personal data shall no longer be processed for such purposes.<br />
<br />
4. At the time of the first communication with you, the right referred to in paragraphs 1 and 2 shall be explicitly brought to your attention of the data subject and shall be presented clearly and separately from any other information.<br />
<br />
5. In the context of the use of information society services, and notwithstanding Directive 2002/58/EC, you may exercise your right to object by automated means using technical specifications.<br />
<br />
6. Where personal data is processed for scientific or historical research purposes or statistical purposes, you, on grounds relating to your particular situation, shall have the right to object to processing of your personal data, unless the processing is necessary for the performance of a task carried out for reasons of public interest.<br />
<br />
7.7. Right to object to automated individual decision-making, including profiling<br />
1. You shall have the right not to be subject to a decision based solely on automated processing, including profiling, which produces legal effects concerning you or similarly significantly affects you.<br />
<br />
2. This right shall not apply if the decision:<br />
<br />
is necessary for entering into, or performance of, a contract between you and the data controller;<br />
is authorised by European Union or Swiss law and which also lays down suitable measures to safeguard the data subject’s rights and freedoms and legitimate interests; or<br />
is based on your explicit consent.<br />
3. In the cases referred to in sub-paragraph (i) and (iii) above, the data controller shall implement suitable measures to safeguard your rights and freedoms and legitimate interests, including the right to obtain human intervention on the part of the controller, to express their point of view and to contest the decision.<br />
<br />
7.8. Right to unsubscribe<br />
If you no longer wish to receive communications from BioAlps Association, you may opt out by cancelling your subscription on the BioAlps Association Site through the link sent in each email you receive from BioAlps Association, or by sending an email to &#x63;&#111;n&#x74;&#97;&#99;&#x74;&#x40;&#98;i&#x6f;&#97;l&#x70;&#x73;&#46;o&#x72;&#103;.<br />
<br />
7.9. Right to lodge a complaint<br />
You can contact the Swiss supervisory authority, the Federal Data Protection and Information Commissioner (FDPIC): https://www.edoeb.admin.ch<br />
<br />
8. Cookies Policy<br />
 <br />
8.1. General<br />
The Site uses “cookies” (i.e., small text files which are downloaded to a user’s device when visiting the Site) in order to improve navigation around the Site for the user and improve the quality of the Site. Cookies which are not necessary are disabled by default. If you want to benefit of all functionalities of the website, you can manage your Cookies settings here. <br />
<br />
If you do not accept optional cookies below, your experience may be affected but that does not prevent you from navigating in the website.<br />
<br />
By authorizing optional cookies, you agree to the deposit and reading of cookies and the use of tracking technologies necessary for their proper functioning.<br />
<br />
When you consent to be contacted by BioAlps Association to receive news alerts or email events, be informed that they contain trackers to ensure their good reception in order to update the list of recipients, to automatically register your unsubscribing and to measure the overall interest in the subjects discussed.<br />
<br />
8.2. Audience measurement<br />
The audience measurement services used to generate useful statistics attendance to improve the site. We use Matomo Analytics.<br />
<br />
We use Matomo Analytics Suite as our website/app analytics software and consent management tool. We collect data about website visitors based on cookies. The collected information may include a visitor’s IP address, operating system, browser ID, browsing activity and other information. <br />
<br />
We calculate metrics like bounce rate, page views, sessions and the like to understand how our website/app is used. We may also create visitors’ profiles based on browsing history to analyze visitor behavior, show personalized content and run online campaigns.<br />
<br />
Matomo Analytics is implemented by WNG, our digital communications agency, the data is stored for 24 months in their datacenter located at SwissCenter (division commerciale de OpenBusiness S. A.), World Trade Center, Av. Gratta-Paille 2, CH-1018 Lausanne (Switzerland).<br />
<br />
The purpose of data processing: analytics and conversion tracking based on consent. Legal basis: Art. 6 (1)(a) GDPR.<br />
<br />
Matomo Analytics does not send the data about you to any other sub-processors or third parties and does not use it for its own purposes. For more, read Matomo Analytics’ privacy policy.<br />
<br />
Processing your personal data such as cookies is helping us identify what is working and what is not on our website. For example, it helps us identify if the way we are communicating is engaging or not and how we can organize the structure of the website better. Our team is benefiting from the processing of your personal data, and they are directly acting on the website. By processing your personal data, you can profit from a website which is getting better and better.<br />
<br />
Without the data, we would not be able to provide you the service we are currently offering to you. Your data will be used only to improve the user experience on our website and help you find the information you are looking for.<br />
<br />
8.3. Managing Cookies of your browser<br />
If you choose to deactivate cookies, some functionalities, pages or parts of the Site may not be accessible. BioAlps Association is not responsible in such cases.<br />
<br />
For more information related to cookies parameters, you can consult the following websites:<br />
<br />
– CNIL – http://www.aboutcookies.org/en<br />
<br />
– Internet Explorer™ – http://windows.microsoft.com/fr-FR/windows-vista/Block-or-allow-cookies <br />
<br />
– Safari™ –http://support.apple.com/kb/ht1677?viewlocale=fr_FR<br />
<br />
– Chrome™ – https://support.google.com/chrome/answer/95647?hl=fr<br />
<br />
– Firefox™ – https://support.mozilla.org/fr/kb/activer-desactiver-cookies<br />
<br />
9. Links to Other Sites<br />
The https://bioalps.org/ site may contain links to or from a number of third party websites (hereinafter referred to as “Third Party Sites”). BioAlps Association does not, in any way, control or operate the Third Party Sites. BioAlps Association is not responsible for the privacy practices, content, policies or actions of the Third Party Sites. This Privacy Policy is only applicable to general information processed by the BioAlps Association Sites, pursuant to information collected on BioAlps Association Sites. The use of any information you may provide to third parties on Third Party Sites, or which such parties may otherwise collect on other websites, is not governed by this Privacy Policy.<br />
<br />
10. Social Networks<br />
Social media plug-ins of social networks such as Facebook, Twitter and LinkedIn or services with user-generated content features are integrated into the BioAlps Association Sites. Where the BioAlps Association Sites contain a plug-in to a social network site, these are clearly marked (e.g. with a LinkedIn button). If you choose to click on one of these buttons or links, your browser connects directly to the servers of the relevant social network. The other website’s privacy policy applies to any personal information you provide to that website. If you do not want the social network to collect the information about you, please review the privacy policy of the relevant social network and/or log out of the relevant social network before you visit the BioAlps Association Site. <br />
<br />
11. Intellectual Property (IP) / Content<br />
All content displayed on the BioAlps Association Sites, including but not limited to, text, graphics, logos, buttons, icons, images, sounds, audio clips, digital downloads, data compilations and software, is the property of BioAlps Association or its content suppliers and is protected by the Swiss and/or foreign applicable laws.<br />
<br />
Registered trademarks of BioAlps Association are marks indicated on the BioAlps Association Sites and include licensors, in Switzerland and other countries. All other trademarks that appear on the BioAlps Association Sites are the property of their respective owners.<br />
<br />
You are prohibited from using, without permission, any of the marks, trademarks, trade names, service names, logos or other proprietary graphic appearing throughout the BioAlps Association Sites.  <br />
<br />
12. Updates to Privacy Policy<br />
To the extent permitted by applicable law in your jurisdiction, BioAlps Association may, from time to time, revise or update this Privacy Policy. You agree to be bound by such modifications or updates. If we make material revisions to the way we collect or use your personal information such that we are using it for purposes that you have not consented to, we will notify you of the changes and, as the case may be, ask for your explicit consent.<br />
<br />
Any changes to this Privacy Policy will become effective upon posting of the revised Privacy Policy on the Internet, accessible through the BioAlps Association Sites. By continuing to use the BioAlps Association following such changes, you will be deemed to have agreed to such changes.</div></fieldset></div></div>
        <div class='gform-footer gform_footer top_label'> <input type='submit' id='gform_submit_button_14' class='gform_button button' onclick='gform.submission.handleButtonClick(this);' data-submission-type='submit' value='Submit'  /> 
            <input type='hidden' class='gform_hidden' name='gform_submission_method' data-js='gform_submission_method_14' value='postback' />
            <input type='hidden' class='gform_hidden' name='gform_theme' data-js='gform_theme_14' id='gform_theme_14' value='gravity-theme' />
            <input type='hidden' class='gform_hidden' name='gform_style_settings' data-js='gform_style_settings_14' id='gform_style_settings_14' value='[]' />
            <input type='hidden' class='gform_hidden' name='is_submit_14' value='1' />
            <input type='hidden' class='gform_hidden' name='gform_submit' value='14' />
            
            <input type='hidden' class='gform_hidden' name='gform_currency' data-currency='CHF' value='9ABjV3/kuiBqF7OBwLbb33Z7KCxj0QMOtGQIYCyB4N0Yk5V7wJPSx5d76nAWcuY3KK6Pv6tB79FmdzhODTVaauT+vFQXVacfeb984z8Ygp5j1Vg=' />
            <input type='hidden' class='gform_hidden' name='gform_unique_id' value='' />
            <input type='hidden' class='gform_hidden' name='state_14' value='WyJ7XCIyNi4xXCI6XCJkM2NjMDFmYTBhNjYwYjhjNjY4YzQ2NWI2NDhjMTVlMVwiLFwiMjYuMlwiOlwiNDExNWUxMDBiZmY0ODY4NTJmMWFiNjVjZTkzOGY5ZmNcIixcIjI2LjNcIjpcIjYzOWEwYjZlNzdlZDYxMTZhZDQ3ODMxNzYwZGY3YTU2XCJ9IiwiODRlYWU2Njc2NWQ1NGU5ZjlhNTQyMzc5MzYyYzNlNmYiXQ==' />
            <input type='hidden' autocomplete='off' class='gform_hidden' name='gform_target_page_number_14' id='gform_target_page_number_14' value='0' />
            <input type='hidden' autocomplete='off' class='gform_hidden' name='gform_source_page_number_14' id='gform_source_page_number_14' value='1' />
            <input type='hidden' name='gform_field_values' value='' />
            
        </div>
                        </form>
                        </div><script>
gform.initializeOnLoaded( function() {gformInitSpinner( 14, 'https://bioalps.org/app/plugins/gravityforms/images/spinner.svg', true );jQuery('#gform_ajax_frame_14').on('load',function(){var contents = jQuery(this).contents().find('*').html();var is_postback = contents.indexOf('GF_AJAX_POSTBACK') >= 0;if(!is_postback){return;}var form_content = jQuery(this).contents().find('#gform_wrapper_14');var is_confirmation = jQuery(this).contents().find('#gform_confirmation_wrapper_14').length > 0;var is_redirect = contents.indexOf('gformRedirect(){') >= 0;var is_form = form_content.length > 0 && ! is_redirect && ! is_confirmation;var mt = parseInt(jQuery('html').css('margin-top'), 10) + parseInt(jQuery('body').css('margin-top'), 10) + 100;if(is_form){jQuery('#gform_wrapper_14').html(form_content.html());if(form_content.hasClass('gform_validation_error')){jQuery('#gform_wrapper_14').addClass('gform_validation_error');} else {jQuery('#gform_wrapper_14').removeClass('gform_validation_error');}setTimeout( function() { /* delay the scroll by 50 milliseconds to fix a bug in chrome */  }, 50 );if(window['gformInitDatepicker']) {gformInitDatepicker();}if(window['gformInitPriceFields']) {gformInitPriceFields();}var current_page = jQuery('#gform_source_page_number_14').val();gformInitSpinner( 14, 'https://bioalps.org/app/plugins/gravityforms/images/spinner.svg', true );jQuery(document).trigger('gform_page_loaded', [14, current_page]);window['gf_submitting_14'] = false;}else if(!is_redirect){var confirmation_content = jQuery(this).contents().find('.GF_AJAX_POSTBACK').html();if(!confirmation_content){confirmation_content = contents;}jQuery('#gform_wrapper_14').replaceWith(confirmation_content);jQuery(document).trigger('gform_confirmation_loaded', [14]);window['gf_submitting_14'] = false;wp.a11y.speak(jQuery('#gform_confirmation_message_14').text());}else{jQuery('#gform_14').append(contents);if(window['gformRedirect']) {gformRedirect();}}jQuery(document).trigger("gform_pre_post_render", [{ formId: "14", currentPage: "current_page", abort: function() { this.preventDefault(); } }]);        if (event && event.defaultPrevented) {                return;        }        const gformWrapperDiv = document.getElementById( "gform_wrapper_14" );        if ( gformWrapperDiv ) {            const visibilitySpan = document.createElement( "span" );            visibilitySpan.id = "gform_visibility_test_14";            gformWrapperDiv.insertAdjacentElement( "afterend", visibilitySpan );        }        const visibilityTestDiv = document.getElementById( "gform_visibility_test_14" );        let postRenderFired = false;        function triggerPostRender() {            if ( postRenderFired ) {                return;            }            postRenderFired = true;            gform.core.triggerPostRenderEvents( 14, current_page );            if ( visibilityTestDiv ) {                visibilityTestDiv.parentNode.removeChild( visibilityTestDiv );            }        }        function debounce( func, wait, immediate ) {            var timeout;            return function() {                var context = this, args = arguments;                var later = function() {                    timeout = null;                    if ( !immediate ) func.apply( context, args );                };                var callNow = immediate && !timeout;                clearTimeout( timeout );                timeout = setTimeout( later, wait );                if ( callNow ) func.apply( context, args );            };        }        const debouncedTriggerPostRender = debounce( function() {            triggerPostRender();        }, 200 );        if ( visibilityTestDiv && visibilityTestDiv.offsetParent === null ) {            const observer = new MutationObserver( ( mutations ) => {                mutations.forEach( ( mutation ) => {                    if ( mutation.type === 'attributes' && visibilityTestDiv.offsetParent !== null ) {                        debouncedTriggerPostRender();                        observer.disconnect();                    }                });            });            observer.observe( document.body, {                attributes: true,                childList: false,                subtree: true,                attributeFilter: [ 'style', 'class' ],            });        } else {            triggerPostRender();        }    } );} );
</script>
</p>
<p>The post <a href="https://bioalps.org/bioalps-awards-nomination-2025/">BioAlps Industry Award Nomination 2025</a> appeared first on <a href="https://bioalps.org">BioAlps</a>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
